Medicare Enrolled
Dr. Anthony Fernandez, M.D., PH.D
Student in an Organized Health Care Education/Training Program · Cleveland, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fernandez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fernandez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fernandez
Dr. Anthony Fernandez is a student in an organized health care education/training program specialist in Cleveland, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fernandez performed 2,873 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fernandez received a total of $366,996 from 23 pharmaceutical and/or device companies across 323 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fernandez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in OH
$366,996 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,873
Medicare services
Top 3% in OH for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
1,812 | $24 | $257 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
189 | $20 | $156 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
124 | $26 | $165 |
| Additional antibody stain test An additional laboratory test using a single antibody stain to evaluate specific markers. |
117 | $23 | $111 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
114 | $7 | $135 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $67 | $419 |
| Surgical pathology consultation on referred slides A pathologist reviews and reports on tissue slides that were prepared at another facility. This service provides a second opinion or expert analysis of the existing samples. |
68 | $72 | $277 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
65 | $41 | $270 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
60 | $1 | $19 |
| Initial single antibody stain evaluation A laboratory test that uses a single antibody stain to evaluate specific proteins or markers in a sample. |
49 | $28 | $112 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
40 | $17 | $103 |
| Moderately high complexity pathology tissue examination A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation. |
28 | $61 | $802 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $61 | $434 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
19 | $36 | $303 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
19 | $31 | $237 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $96 | $638 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
15 | $36 | $226 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $60 | $437 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
14 | $64 | $733 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
13 | $21 | $267 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$366,996
Total received (2018-2024)
Avg $52,428/year across 7 years
Top 0% in OH for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
323
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$66,589
2023
$56,852
2022
$16,313
2021
$37,096
2020
$39,438
2019
$75,852
2018
$74,857
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$31,742
ABBVIE INC.
$13,081
Mallinckrodt Hospital Products Inc.
$10,356
Therakos Healthcare LLC
$9,909
Galderma Laboratories, L.P.
$1,191
Dermavant Sciences, Inc.
$121
Novartis Pharmaceuticals Corporation
$99
Kyowa Kirin, Inc.
$90
Top 3 companies account for 82.9% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$79,602
E.R. Squibb & Sons, L.L.C.
$61,052
Mallinckrodt Hospital Products Inc.
$50,779
Novartis Pharmaceuticals Corporation
$29,410
AbbVie Inc.
$28,997
ABBVIE INC.
$26,059
Mallinckrodt LLC
$20,806
Mallinckrodt Enterprises LLC
$19,031
Kyowa Kirin, Inc.
$11,233
UCB, Inc.
$10,397
Therakos Healthcare LLC
$9,909
Celgene Corporation
$4,049
NOVARTIS PHARMACEUTICALS CORPORATION
$4,007
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,100
Alexion Pharmaceuticals, Inc.
$2,838
PFIZER INC.
$2,178
Biogen, Inc.
$1,982
Galderma Laboratories, L.P.
$1,191
Boston Scientific Corporation
$148
Dermavant Sciences, Inc.
$121
GENZYME CORPORATION
$49
Sun Pharmaceutical Industries Inc.
$35
Genentech USA, Inc.
$24
Top 3 companies account for 52.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · CELLEX/XTS PHOTOPHERESIS SYSTEM · CELLEXXTS PHOTOPHERESIS SYSTEM · COSENTYX · DUPIXENT · EUCRISA · HUMIRA · Humira · Otezla · POTELIGEO · Poteligeo · RINVOQ · Rituxan · SKYRIZI · Skyrizi · Sotyktu · TheraSphere Y90 Glass Microspheres 10 GBq · UVADEX · UVADEX METHOXSALEN STERILE SOLUTION · Ultomiris · VTAMA · Winlevi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fernandez is a mixed practice specialist, with above-average Medicare volume (top 3% in OH), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fernandez experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Fernandez performed 1,812 tissue pathology examination, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fernandez receive payments from pharmaceutical companies?
Yes. Dr. Fernandez received a total of $366,996 from 23 companies across 323 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fernandez's costs compare to other student in an organized health care education/training programs in Cleveland?
Dr. Fernandez's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fernandez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Cleveland
Browse student in an organized health care education/training programs in Cleveland ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in OH
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in OH
Which OH student in an organized health care education/training programs receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology